| Sources | Names Used |
|---|---|
| CTRPv2 | BRD-K03536150 |
| PharmacoGx | BRD-K03536150 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | C1orf162 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0005 |
| mRNA | SOGA3 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0005 |
| mRNA | SLC25A33 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0005 |
| mRNA | MMS22L | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |
| mRNA | C18orf32 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |
| mRNA | RILPL2 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0005 |
| mRNA | ELAVL4 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.0005 |
| mRNA | CD83 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |
| mRNA | TMEM63C | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |
| mRNA | BTG2 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0005 |
